Fifteen institutions issued a statement to that effect on Sunday in a bid to counter prevailing scepticism about the existence and treatability of the disease, which affects a growing number of Swiss.
Alzheimer Switzerland and the Memory Center of Geneva University Hospital (HUG) are among the organisations that took this position, in line with the 2014-2019 national strategy on dementia.
Dementia, according to these institutions, is clearly a disease that is not part of the normal ageing process. The causes are mainly neurodegenerative or vascular.
Patients, they say, have the right to receive the best treatment.
“This stance, which is based on long consideration, was necessary for the enormous responsibility that we have towards our patients,” Giovanni Frisoni, director of the HUG Memory Center, told Swiss news agency Keystone-SDA.
Search for therapies
It is also a question of responding to “deniers” for whom Alzheimer’s is not a disease.
“This minority makes a lot of noise but does not contribute in any way to the reflection on the disease and the search for therapies,” Frisoni says.
In France, he notes, the costs of dementia drugs have not been reimbursed by health insurance since last year. The products Aricept, Ebixa, Exelon and Reminyl are the only ones approved and reimbursed in Switzerland.
“Without them there is no alternative,” Frisoni stresses.
Demographic changes
Although these drugs do not treat Alzheimer’s, they have nevertheless proved their effectiveness. They temporarily improve the condition of patients or stabilise cognitive symptoms for up to 18 months, according to the joint statement.
Early diagnosis and treatment also improve people’s autonomy, allowing them to live longer at home. The combination of pharmacological and non-pharmacological therapeutic approaches is necessary and is emphasised in the position paper.
Currently 151,000 people have dementia in Switzerland. Due to demographic changes, the medical community estimates 300,000 people will be affected by dementia in 2040.
More
More
A special kind of home for people with dementia
This content was published on
Around 150,000 people have dementia in Switzerland, with the figure set to double in the next 20 years. What’s the best way to care for these people?
Protein in abdominal fat could help shape obesity treatment
This content was published on
The study analysed fat cells from different locations in the body, and found that those in the abdomen have unique properties.
North African asylum claims fall after rapid Swiss processing
This content was published on
The accelerated procedure, now out of its test phase, has resulted in a significant drop in applications from North African countries.
This content was published on
The artist's song "The Code" focuses on their journey as a nonbinary individual. It is one of the favourites to win this year's contest.
Swiss climate activists block vehicles near Gotthard tunnel
This content was published on
Around ten climate activists briefly blocked the A2 motorway near the northern entrance of the Gotthard tunnel on Thursday.
Watches belonging to Michael Schumacher up for auction
This content was published on
Schumacher's family is auctioning off eight rare watches from his collection in Geneva. The Christie's auction will take place on Monday.
Joya Marleen and Baschi named best solo acts at Swiss Music Awards
This content was published on
St. Gallen singer Joya Marleen and Baschi from Basel were named artists of the year at the Swiss Music Awards 2024 on Wednesday night.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss non-profit aims to break taboo of women’s brain health
This content was published on
If depression is twice as common in women than men worldwide, does that mean we need to change how we think about gender, health, and science?
This content was published on
The director of the Brain Mind Institute at the Federal Institute of Technology in Lausanne is leading a major new national research project, “Synapsy”, into the neurobiological mechanisms behind mental and cognitive disorders. The research, funded by the Swiss National Science Foundation and launched at the beginning of October, aims to bring the two disciplines…
This content was published on
There are far more people with dementia in Switzerland than previously thought – and the number is expected to double over the next 25 years.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.